NCT00717704 2020-08-05
Solid Tumors Using Ixabepilone and Dasatinib
Medstar Health Research Institute
Phase 1 Completed
Clinical Trials
10 trialsNCT01084057 2019-11-05
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00096317 2018-10-31
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00005807 2018-10-09
BMS-247550
Albert Einstein College of Medicine
Phase 1 Completed
NCT01012362 2017-12-28
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT00637897 2017-05-30
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer
Wake Forest University Health Sciences
Phase 1 Completed
NCT00884676 2015-10-09
Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
University of Miami
Phase 1 Completed
NCT01170871 2014-05-21
Ixabepilone and Pemetrexed/Solid Tumors
University of Southern California
Phase 1 Withdrawn
NCT00804310 2012-03-28
UCDCC#207
University of California, Davis
Phase 1 Terminated
NCT01454479 2011-10-19
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
Chang Gung Memorial Hospital
Phase 1 Unknown